Zydus Receives Tentative Approval from USFDA for Ibrutinib Tablets

Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received tentative approval from the United States Food and Drug Administration (USFDA) for Ibrutinib tablets 140 mg, 280 mg, and 420 mg (USRLD

Dr Reddy's Targets Wegovy Market With Generic Obesity Launch

Dr Reddy's Laboratories is poised to launch a lower-cost generic version of Novo Nordisk's obesity drug Wegovy (semaglutide) in 87 markets from next year.

Apollo and Siemens Join Forces to Revolutionize Liver Healthcare with AI

Apollo Hospitals and Siemens Healthineers are poised to redefine the diagnosis and treatment of liver disease. The two have announced a collaboration to innovate advanced clinical liver healthcare through the use of AI-enabled imaging...

Delhi HC bars Zydus from launching Nivolumab biosimilar till 2026

In a courtroom defeat for Zydus Lifesciences, the Delhi High Court has stayed the company from marketing its proposed biosimilar of the cancer drug Nivolumab

Torrent Pharma Launches a New Adult Nutrition Powder, Shelcal Total

In a move to gain traction in the consumer healthcare market, Torrent Pharmaceuticals has launched Shelcal Total, a complete nutrition supplement powder for adults. “India is facing a growing nutrition gap driven by lifestyle changes...

Cipla invests in iCaltech to boost respiratory health portfolio

Cipla Limited said that it entered into definitive agreements to invest in iCaltech Innovations Private Limited by Optionally Convertible Preference Shares.

Godavari Biorefineries Gets China Patent for Promising Cancer Drug

Through its clinical-stage biotech subsidiary Sathgen Therapeutics, Godavari Biorefineries Limited has received a patent for its innovative anti-cancer chemical, HYDROXY-1,4-NAPHTHALENEDIONE, from China's patent and trademark authority, the China

Centre Approves 48 Pharma Projects to Boost Local Manufacturing

In a massive push to turn India pharma-independent, the central government has sanctioned 48 new projects under the PLI scheme to increase domestic production of essential drug ingredients called APIs and KSMs...

ICMR Invites Industry to License Its Indigenous Malaria Vaccine

In a significant boost to the biopharma sector, the Indian Council of Medical Research (ICMR) has issued an Expressions of Interest (EoI) to license its indigenous malaria vaccine, AdFalciVax. The vaccine targets Plasmodium falciparum...

DBT Launches AI-Backed Image Biobanks to Boost Diagnostics

The Department of Biotechnology (DBT) has released a flagship program for establishing a countrywide network of artificial intelligence

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.